StratCare-2 is a clinical trial evaluating the clinical and cost-effectiveness of AI-driven stratified care for depression.
StratCare-2 is a clinical trial evaluating the clinical and cost-effectiveness of AI-driven stratified care for depression.
The study is being led and managed by the Clinical Trials Research Unit at the University of Sheffield. CTRU webpage for StratCare-2
This study is funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme.
All research in the NHS is overseen by an independent group of people, a Research Ethics Committee, to protect your safety, rights, wellbeing and dignity. This trial has been reviewed and approved by the London - Sussex and Brighton REC (Ref: 24/LO/0576, approved on 18/09/2024).